Senate - 12/10/2020 Received in the Senate. (All Actions)
Tracker:
This bill has the status Passed House
Here are the steps for Status of Legislation:
Introduced
Array
(
[actionDate] => 2020-12-07
[displayText] => Reported (Amended) by the Committee on Energy and Commerce. H. Rept. 116-619, Part I.
[externalActionCode] => 5000
[description] => Introduced
[chamberOfAction] => House
)
Passed House
Array
(
[actionDate] => 2020-12-09
[displayText] => Passed/agreed to in House: On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote.
[externalActionCode] => 8000
[description] => Passed House
[chamberOfAction] => House
)
To amend the Controlled Substances Act to make marijuana accessible for use by qualified marijuana researchers for medical purposes, and for other purposes.
Actions Overview (4)
Date
Actions Overview
12/09/2020
Passed/agreed to in House: On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote.
12/07/2020
Committee on the Judiciary discharged.
12/07/2020
Reported (Amended) by the Committee on Energy and Commerce. H. Rept. 116-619, Part I.
07/17/2019
Introduced in House
12/09/2020 Passed/agreed to in House: On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote.
12/07/2020 Committee on the Judiciary discharged.
12/07/2020 Reported (Amended) by the Committee on Energy and Commerce. H. Rept. 116-619, Part I.
07/17/2019 Introduced in House
All Actions (16)
Date
Chamber
All Actions
12/10/2020
Senate
Received in the Senate.
12/09/2020-2:40pm
House
Motion to reconsider laid on the table Agreed to without objection.
12/09/2020-2:40pm
House
On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote. (text: CR H7076-7078)
12/09/2020-2:04pm
House
DEBATE - The House proceeded with forty minutes of debate on H.R. 3797.
12/09/2020-2:04pm
House
Considered under suspension of the rules. (consideration: CR H7076-7083)
12/09/2020-2:04pm
House
Mr. Pallone moved to suspend the rules and pass the bill, as amended.
12/07/2020
House
Placed on the Union Calendar, Calendar No. 508.
12/07/2020
House
Committee on the Judiciary discharged.
12/07/2020
House
Reported (Amended) by the Committee on Energy and Commerce. H. Rept. 116-619, Part I.
09/09/2020
House
Ordered to be Reported (Amended) by Voice Vote. Action By: Committee on Energy and Commerce
09/09/2020
House
Committee Consideration and Mark-up Session Held. Action By: Committee on Energy and Commerce
08/06/2019
House
Referred to the Subcommittee on Crime, Terrorism, and Homeland Security. Action By: Committee on the Judiciary
07/18/2019
House
Referred to the Subcommittee on Health. Action By: Committee on Energy and Commerce
07/17/2019
House
Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
07/17/2019
House
Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
07/17/2019
House
Introduced in House
12/10/2020 Received in the Senate.
12/09/2020 Motion to reconsider laid on the table Agreed to without objection.
12/09/2020 On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote. (text: CR H7076-7078)
12/09/2020 DEBATE - The House proceeded with forty minutes of debate on H.R. 3797.
12/09/2020 Considered under suspension of the rules. (consideration: CR H7076-7083)
12/09/2020 Mr. Pallone moved to suspend the rules and pass the bill, as amended.
12/07/2020 Placed on the Union Calendar, Calendar No. 508.
12/07/2020 Committee on the Judiciary discharged.
12/07/2020 Reported (Amended) by the Committee on Energy and Commerce. H. Rept. 116-619, Part I.
09/09/2020 Ordered to be Reported (Amended) by Voice Vote.
09/09/2020 Committee Consideration and Mark-up Session Held.
08/06/2019 Referred to the Subcommittee on Crime, Terrorism, and Homeland Security.
07/18/2019 Referred to the Subcommittee on Health.
07/17/2019 Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
07/17/2019 Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Committees, subcommittees and links to reports associated with this bill are listed here, as well as the nature and date of committee activity and Congressional report number.
Committee / Subcommittee
Date
Activity
Reports
House Energy and Commerce
07/17/2019
Referred to
09/09/2020
Markup by
12/07/2020
Reported by
House Energy and Commerce Subcommittee on Health
07/18/2019
Referred to
House Judiciary
07/17/2019
Referred to
12/07/2020
Discharged from
House Judiciary Subcommittee on Crime, Terrorism, and Homeland Security
This bill establishes a new, separate registration process to facilitate medical marijuana research.
Specifically, it directs the Drug Enforcement Administration to register (1) practitioners to conduct medical marijuana research, and (2) manufacturers and distributors to supply marijuana for such research.
Additionally, the Department of Health and Human Services must continue to produce marijuana through the National Institute on Drug Abuse Drug Supply Program and offer to sell immature plants and seeds to researchers until manufacturers and distributors can provide a sufficient supply of marijuana for medical research.
All Summaries (1)
Shown Here: Introduced in House (07/17/2019)
Medical Marijuana Research Act of 2019
This bill establishes a new, separate registration process to facilitate medical marijuana research.
Specifically, it directs the Drug Enforcement Administration to register (1) practitioners to conduct medical marijuana research, and (2) manufacturers and distributors to supply marijuana for such research.
Additionally, the Department of Health and Human Services must continue to produce marijuana through the National Institute on Drug Abuse Drug Supply Program and offer to sell immature plants and seeds to researchers until manufacturers and distributors can provide a sufficient supply of marijuana for medical research.